Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA1 | P02708 | 3/20 | 0.52 |
| ▸ | CHRNG | P07510 | 3/20 | 0.52 |
| ▸ | CHRNB1 | P11230 | 3/20 | 0.52 |
| ▸ | CHRND | Q07001 | 3/20 | 0.52 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.52 |
| ▸ | CASP3 | P42574 | 2/20 | 0.51 |
| ▸ | CASP7 | P55210 | 1/20 | 0.51 |
| ▸ | CTSB | P07858 | 3/20 | 0.51 |
| ▸ | CASP1 | P29466 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CTSL | P07711 | 1/20 | 0.49 |
| ▸ | CTSS | P25774 | 1/20 | 0.49 |
| ▸ | CASP9 | P55211 | 1/20 | 0.49 |
| ▸ | REN | P00797 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.45 |
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29538222 | 0.91 | OPRD1 (0.49) | CHRNA1CHRNGCHRNB1CHRNDGRIA1 | |
| SCHEMBL31010534 | 0.91 | CTSD (0.54) | CASP3CASP7CTSBCASP1SMN1; SMN2 | |
| SCHEMBL9219464 | 0.91 | CTSD (0.54) | CASP3CASP7CTSBCASP1SMN1; SMN2 | |
| Tyropeptin A SCHEMBL2808523 | 0.86 | CASP1 (0.50) | CASP3CASP7CTSBCASP1SMN1; SMN2 | |
| Tyropeptin A SCHEMBL29843181 | 0.86 | CASP1 (0.50) | CASP3CASP7CTSBCASP1SMN1; SMN2 | |
| Tyropeptin A SCHEMBL2808528 | 0.86 | CASP1 (0.50) | CASP3CASP7CTSBCASP1SMN1; SMN2 | |
| SCHEMBL29426382 | 0.86 | OPRD1 (0.48) | CASP3CASP7CASP1CASP9OPRD1 | |
| SCHEMBL30467221 | 0.82 | MMP2 (0.48) | CASP3CASP7CASP1CASP9REN | |
| SCHEMBL29434519 | 0.82 | OPRD1 (0.54) | GRIA1CTSBCASP1CTSSOPRD1 | |
| SCHEMBL622416 | 0.82 | CTSB (0.54) | GRIA1CASP3CASP7CTSBCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119909033-A | Esomeprazole magnesium enteric-coated particles and preparation method thereof | 江苏海之宏生物医药有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119652203-A | Closed-loop control method for motor | 广东晟辉科技股份有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-221042337-U | Vehicle-mounted high-power USB charging module | 科博达技术股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-221042338-U | Vehicle-mounted high-power USB data charging module | 科博达技术股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-220421459-U | Vehicle-mounted charging circuit with double USB interfaces | 科博达技术股份有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-220234228-U | Vehicle-mounted high-power USB data charging module | 科博达技术股份有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-116961167-A | Vehicle-mounted charging circuit with double USB interfaces | 科博达技术股份有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-116683580-A | Vehicle-mounted high-power USB charging module | 科博达技术股份有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-116683582-A | Vehicle-mounted high-power USB data charging module | 科博达技术股份有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-116683581-A | Vehicle-mounted high-power USB data charging module | 科博达技术股份有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-115844854-A | Microcapsule type self-suspending theophylline sustained release granule and preparation method thereof | 沈阳药科大学 | 2023-03-28 | — | — | CN | claimed |
| US-12636361-B2 | Smallpox vaccine for cancer treatment | CALIDI BIOTHERAPEUTICS (NEVADA), INC. (US) | 2026-05-26 | — | — | US | disclosed |
| EP-4731770-A1 | CHIMERIC PROTEINS FOR MODULATING CYTOKINE RECEPTOR ACTIVITY | Ablynx NV (BE) | 2026-04-29 | — | — | EP | disclosed |
| EP-3251301-B1 | SYSTEM AND METHOD FOR A GLOBAL VIRTUAL NETWORK | UMBRA TECH LTD (CN) | 2026-04-08 | — | — | EP | disclosed |
| US-20260019302-A1 | SYSTEM AND METHOD FOR A GLOBAL VIRTUAL NETWORK | UMBRA TECHNOLOGIES LTD. (CN) | 2026-01-15 | — | — | US | disclosed |
| CN-115212301-A | Smallpox vaccine for cancer treatment | 卡利迪生物治疗有限公司 | 2022-10-21 | — | — | CN | disclosed |
| CN-113285864-B | System and method for global virtual network | 安博科技有限公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-108135996-B | Smallpox vaccine for cancer treatment | 卡利迪生物治疗有限公司 | 2022-06-21 | — | — | CN | disclosed |
| US-20220158867-A1 | SYSTEM AND METHOD FOR A GLOBAL VIRTUAL NETWORK | UMBRA TECHNOLOGIES LTD. (CN) | 2022-05-19 | — | — | US | disclosed |
| US-11240064-B2 | System and method for a global virtual network | UMBRA TECHNOLOGIES LTD. (CN) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636361-B2 | Smallpox vaccine for cancer treatment | BMX, TP53, PBK | CHRNA1 3268/4885CHRNG 2530/4885CHRNB1 2893/4885 |
| US-20260019302-A1 | SYSTEM AND METHOD FOR A GLOBAL VIRTUAL NETWORK | STAT4, NECTIN4, STAT3 | CHRNA1 2210/4885CHRNG 1676/4885CHRNB1 2413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.